Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
11 results loaded, newest first. End of these results.
Pfizer (NYSE: PFE ) released second-quarter financial results and hosted an earnings call on Tuesday. Read the complete transcript below. APIs provide real-time access to earnings call transcripts and financial data. Visit to learn more. Access the full call at Summary Full Transcript OPERATOR Good day everyone and wel
Arvinas (NASDAQ: ARVN ) reported second-quarter financial results on Tuesday. The transcript from the company's second-quarter earnings call has been provided below. APIs provide real-time access to earnings call transcripts and financial data. Visit to learn more. Access the full call at Summary Arvinas Inc. reported
BeiGene (NASDAQ: ONC ) held its second-quarter earnings conference call on Wednesday. Below is the complete transcript from the call. This content is powered APIs. For comprehensive financial data and transcripts, visit View the webcast at Summary BeiGene reported strong Q2 2026 financial results with $1.7 billion in t
Alphabet (NASDAQ: GOOGL ) reported second-quarter financial results on Wednesday. The transcript from the company's second-quarter earnings call has been provided below. This transcript is brought to you APIs. For real-time access to our entire catalog, please visit for a consultation. View the webcast at Summary Alpha
Alphabet (NASDAQ: GOOG ) held its second-quarter earnings conference call on Wednesday. Below is the complete transcript from the call. This transcript is brought to you APIs. For real-time access to our entire catalog, please visit for a consultation. View the webcast at Summary Alphabet's second quarter 2026 revenue
Novavax shares are trading higher Tuesday after U.S. FDA emergency use authorization for its updated 2026-2027 Nuvaxovid vaccine and an earlier Q2 update that raised full-year revenue guidance.
US and Iran talks ongoing with all parties
Rev. $15.03B (est $14.41B) - Raises Midpoint Of 2026 Rev. Guidance - Announces Expansion Of Productivity Initiatives - Eliquis Rev 2.43B (est 2.09B) - Prevnar Franchise Rev $1.34B (est $1.38B) - Now Expects Total Net Cost Savings Of $6.7 Billion - Still Sees FY Adj EPS $2.80 To $3.00 - Sees FY Rev. $60.5B To $62.5B, Sa
Pfizer Q2 2026 Earnings
() -- Biopharma pricing power will be the key swing factor for Q2 earnings as companies with cleaner growth outlooks continue to outperform peers facing loss-of-exclusivity headwinds, Bank of America said in a note Friday. Merck & Co (MRK), AbbVie (ABBV), Jazz Pharmaceuticals (JAZZ) and Ionis Pharmaceuticals (IONS) rem
() -- Pfizer (PFE) is expected to report Q2 revenue in line with consensus estimates, while earnings per share are likely to come in about 3% below expectations due to an unfavorable gross margin mix and higher research and development spending to support pipeline programs, RBC Capital said in a Friday preview note. Th